Literature DB >> 8482445

Menetrier's disease: a form of hypertrophic gastropathy or gastritis?

H C Wolfsen1, H A Carpenter, N J Talley.   

Abstract

BACKGROUND: Menetrier's disease is characterized by giant gastric folds and foveolar hyperplasia. The extent of mucosal inflammation and glandular atrophy, however, is controversial. The aim of this study was to test the hypothesis that patients previously diagnosed with Menetrier's disease actually represent at least two diseases: (1) Hypertrophic lymphocytic gastritis (HLG) and (2) Massive foveolar hyperplasia and minimal inflammation (MFH).
METHODS: All cases of possible Menetrier's disease were identified, and their clinical, laboratory, and pathological data were reviewed. In twenty-three patients with giant fundal folds, full-thickness tissue specimens (n = 19) or large suction biopsy (n = 4) tissue specimens were obtained.
RESULTS: Two distinct, nonoverlapping histological patterns were found; 13 patients had HLG and 10 patients had MFH. Clinical features and frequency of Helicobacter pylori were similar in these two groups. Patients with HLG had severe inflammation with numerous intraepithelial lymphocytes and mild foveolar hyperplasia. Alternatively, patients with MFH had greater foveolar hyperplasia, significantly thicker mucosa, and greater mucosal edema.
CONCLUSIONS: Patients with MFH represent a form of hypertrophic gastropathy and should be designated as having Menetrier's disease, whereas patients with HLG should be considered part of the spectrum of lymphocytic gastritis.

Entities:  

Mesh:

Year:  1993        PMID: 8482445     DOI: 10.1016/0016-5085(93)90339-e

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

1.  Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy.

Authors:  L G Madsen; M Taskiran; J L Madsen; P Bytzer
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Helicobacter pylori-associated protein-losing hypertrophic gastropathy with hypercholesterolemia.

Authors:  A N Kapsoritakis; S Potamianos; E Matrella; S Koukouraki; E Oeconomaki; M Tzardi; N Karkavitsas; E A Kouroumalis
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

Review 3.  Emerging gastritides.

Authors:  W M Weinstein
Journal:  Curr Gastroenterol Rep       Date:  2001-12

4.  Distinguishing Ménétrier's disease from its mimics.

Authors:  Amy Rich; Tania Zuluaga Toro; Jarred Tanksley; William H Fiske; Christopher D Lind; Gregory D Ayers; Hubert Piessevaux; Mary K Washington; Robert J Coffey
Journal:  Gut       Date:  2010-10-06       Impact factor: 23.059

5.  A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release.

Authors:  Giovanni Di Nardo; Salvatore Oliva; Marina Aloi; Federica Ferrari; Simone Frediani; Adriana Marcheggiano; Salvatore Cucchiara
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 6.  Beyond gastritis and before cancer: the strange case of Ménétrier's disease.

Authors:  Giuseppe Famularo; Maria Rosaria Sajeva; Laura Gasbarrone
Journal:  Intern Emerg Med       Date:  2010-10-14       Impact factor: 3.397

7.  Ménétrier's disease.

Authors:  G Sisson; A W Harris
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

8.  Lymphocytic gastritis, gastric adenocarcinoma, and primary gastric lymphoma.

Authors:  A P Griffiths; J Wyatt; A S Jack; M F Dixon
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

9.  Loss of parietal cell expression of Sonic hedgehog induces hypergastrinemia and hyperproliferation of surface mucous cells.

Authors:  Chang Xiao; Sally A Ogle; Michael A Schumacher; Melissa A Orr-Asman; Marian L Miller; Nantaporn Lertkowit; Andrea Varro; Frederic Hollande; Yana Zavros
Journal:  Gastroenterology       Date:  2009-11-10       Impact factor: 22.682

Review 10.  Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons.

Authors:  Gregory Y Lauwers; Hiroshi Fujita; Koji Nagata; Michio Shimizu
Journal:  J Gastroenterol       Date:  2009-12-05       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.